The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of gemcitabine and bendamustine in relapsed/refractory Hodgkin's lymphoma.
 
Jonathon Brett Cohen
Consulting or Advisory Role - Millennium; Pharmacyclics; Seagen
Research Funding - Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Idera
 
Lai Wei
No Relationships to Disclose
 
Kami J. Maddocks
No Relationships to Disclose
 
Leonard T. Heffner
No Relationships to Disclose
 
Amelia A. Langston
No Relationships to Disclose
 
Christopher Flowers
Consulting or Advisory Role - Algeta ASA; OptumRx; Seagen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); Spectrum Pharmaceuticals (Inst); TG Therapeutics (Inst)
Other Relationship - Celgene
 
Steven M Devine
No Relationships to Disclose
 
Kristie A. Blum
No Relationships to Disclose